|
|
 |
| Metabasis is a biopharmaceutical company focused on the discovery,
development and commercialization of novel drugs by applying its proprietary
technologies, scientific expertise and unique capabilities for targeting
the liver and liver pathways. The Company has established a broad
pipeline of product candidates and advanced research programs targeting
large markets with significant unmet needs. Metabasis' product pipeline
represents drug candidates indicated for the treatment of metabolic
diseases such as hyperlipidemia and diabetes, among others. Additionally,
our pipeline includes drug candidates for the treatment of liver diseases
such as hepatitis and primary liver cancer which the company plans
to license. All product candidates were developed internally using
proprietary technologies including the Company's NuMimetic and HepDirect
technologies. |
|
May 8, 2008
Metabasis to Present at the Bank of America 2008 Health
Care Conference more
May 1, 2008
Metabasis Therapeutics Announces First Quarter 2008 Results
and Recent Highlights more
|
|
| | |
